Objective: To examine longitudinal changes in serum cobalamins, transcobalamin (TC) and haptocorrin (HC) during lactation and to investigate the influence of vitamin B 12 supplementation on these parameters. Design: A 9-month follow-up study. Subjects and methods: Lactating mothers (N ¼ 89) including 23 supplemented with vitamin B 12 (1-18 mg/daily), 41 partly supplemented and 25 not supplemented. Blood samples collected 3 weeks (baseline) and 4 and 9 months post-partum were analysed for cobalamins, TC and HC. Both the total concentration and the cobalamin-saturated form (holo) of TC and HC were analysed. Results: No significant differences were observed in serum cobalamins or its binding proteins related to supplementation with vitamin B 12 or the duration of lactation. Serum cobalamins remained unchanged from 3 weeks to 9 months post-partum. Total TC (holoTC) (median7s.e. pmol/l) decreased between 3 weeks (710723 (85712)) and 9 months (602721 (76711)) (Po0.0001 (P ¼ 0.0002)), whereas total HC (holoHC) increased from (422711 (30079)) at 4 months to (455713 (317710)) to 9 months post-partum (Po0.0001 (Po0.0001)). Conclusion: We report a decrease in TC and an increase in HC during a 9-month period post-partum. No differences were observed between the vitamin B 12 -supplemented and the unsupplemented groups. Thus, supplementation with vitamin B 12 has no impact on the circulating level of serum cobalamins or its binding proteins in a Danish population of lactating mothers.
Introduction
The requirements for many micronutrients such as vitamin B 12 are higher during pregnancy and lactation owing to transfer to the baby (Allen, 1994; Mackey and Picciano, 1999) . A few studies have shown that the vitamin B 12 status of the mother is associated with the content of vitamin B 12 in breast milk (Baker et al., 1962; Black et al., 1994) and with the vitamin B 12 status of the baby (Specker et al., 1988) , indicating that the amount of vitamin B 12 released into the breast milk and thereby available to the baby depends on the vitamin B 12 status of the mother.
Many babies have low serum levels of cobalamins Minet et al., 2000; Monsen et al., 2001) . In most cases, an apparent vitamin B 12 deficiency may be attributed to a low vitamin B 12 status in the mother (Specker et al., 1988 Casterline et al., 1997; Ueland and Monsen 2003) . These observations suggest that lactating mother do not have a sufficient intake of vitamin B 12 to ensure the needs of both the mother and the baby and emphasize the need to examine the status of cobalamin and its binding proteins in lactating mothers.
In healthy non-pregnant adults, most of the circulating cobalamins are bound to haptocorrin (HC) , and this protein is almost fully saturated with vitamin B 12 (holoHC). Less than one-third of the circulating cobalamins are bound to transcobalamin (TC), and most of this protein circulates unsaturated with cobalamins. HoloTC is the metabolically active form responsible for the transport of cobalamin to the cells and thereby also for the delivery of cobalamin to the mammary glands (Nexo and Hollenberg, 1980; Willis et al., 1989) .
Longitudinal data on the level of the cobalamin-binding proteins and cobalamins during lactation are limited (Fernandes-Costa and Metz, 1982; Dostálová, 1984; Donangelo et al., 1989) . Moreover, the available data were reported before the development of assays that measure the binding proteins HC and TC directly (Nexø et al., 2000; Mørkbak et al., 2005) .
The aim of the present study was to examine the longitudinal changes in serum cobalamins and in total and holoTC and holoHC during lactation and to investigate the influence of vitamin B 12 supplementation on these parameters.
Subjects and methods

Study design and populations
The study was designed as a follow-up study including 91 healthy mothers. Two non-lactating individuals were excluded. The study population has previously been described in detail (Ramlau-Hansen et al., 2006) . Briefly, the participants were apparently healthy with no use of medication and no abuse of alcohol, uncomplicated pregnancy and a blood loss less than 500 ml during labour. They gave birth to a single child at a gestation age of 38-42 weeks and with a birth weight of more than 2500 g. Blood samples were drawn at baseline (3 weeks post-partum), first follow-up (4 months post-partum) and second follow-up (9 months post-partum). At all three collections, the participants were interviewed with respect to degree of lactation and use of vitamin supplements (name of preparation and dose). Furthermore, smoking habits, coffee and alcohol intake, medications, exercise level, illnesses and diet (meat eater or vegetarian) were registered. The study was approved by the local ethics committee (project nos. 20030093 and 20030094) and monitored by the local unit for Good Clinical Practice.
For establishment of a reference interval, plasma samples from 71 healthy female donors (age: 23-61 years) were also analysed.
Sampling and analytical methods
Venous blood was drawn for preparation of serum and plasma at 3 weeks (baseline) and 4 and 9 months postpartum. Samples were stored at À201C until use. Serum cobalamins were measured on the Advia Centauer from Bayer A/S, Leverkusen, Germany. Total TC and HC in serum were measured by in-house sandwich enzyme-linked immunosorbent assay (ELISA) (Nexø et al., 2000; Mørkbak et al., 2005) . Total coefficient of variation (CV) was less than 10%.
Serum holoHC (holoTC) was quantified by measurement of the amount of HC (TC) not removed by treating the samples with vitamin B 12 -covered beads following the protocol developed for measurement of holoTC (Nexø et al., 2002) . In brief, 90 ml of serum was pretreated with neuraminidase and peptide N-glycosidase F dissolved in phosphate buffer, 0.1 mol/l pH 7.4, as described by Mørkbak et al (Mørkbak et al., 2005) . For measurement of holoHC, 100 ml of pretreated serum solution was incubated for 1 h with 10 ml vitamin B 12 beads before magnetic separation of the beads from the supernatant containing the holoHC. A 290 ml portion of 0.1 M sodium phosphate buffer pH 8.0 containing 0.1% human albumin was added to 50 ml supernatant, and holoHC was analysed by the same ELISA as used for measurement of total HC. The total CV for the holoHC assay was 10% at 157 pmol/l (43 estimates determined in 43 runs) and 9% at 194 pmol/l (40 estimates determined in 40 runs).
TC saturation was calculated as holoTC divided by total TC; likewise, HC saturation was calculated as holoHC divided by total HC.
Prolactin in plasma was measured using the Immuno Assay system on the Advia Centauer from Bayer A/S, Leverkusen, Germany.
Statistical analyses
The distribution of weight, cobalamins, prolactin, TC and HC (holo and total) was skewed, and therefore statistical analysis was performed using non-parametric statistics (Mann-Whitney test, Wilcoxon matched pair signed-ranks test and Friedman's test (Po0.05)). Associations were analysed using linear regression. All statistics were performed in GraphPad Prism version 4.00 for Windows (GraphPad Software, San Diego, CA, USA, www.graphpad.com).
Results
The study population was 89 post-partum lactating mothers with a lactation period ranging from 1.5 to more than 9 months (51% had not stopped lactating after 9 months). The median (range) duration of the lactation period for the 42 women who had stopped lactating at 9 months was 28 weeks (6-40 weeks).
Of the 89 mothers, 23 were supplemented with vitamin B 12 (1-18 mg, median ¼ 1 mg per day) through out follow-up, 41 were partly supplemented (1-9 mg, median ¼ 1 mg per day indicated at one or two of the visits) and 25 were not supplemented at all. Selected baseline characteristics of the 89 lactating women are listed in Table 1 . A statistically significant decrease in the weight of the lactating mothers (range 3.5-(À14) kg, median ¼ À4.1 kg) was observed from baseline to 9 months post-partum (Friedman's test, Po0.0001). This decrease showed a weak but statistically significant positive association with the increase in holoHC (r 2 ¼ 0.06, P ¼ 0.02, n ¼ 86) and cobalamins (r 2 ¼ 0.05,
No associations were seen with changes in holoTC, total TC or total HC. The weight of the baby increased (range 2895-7980 g, median ¼ 4880 g) from baseline to 9 months post-partum. The increase was not associated with the change in cobalamins, TC or HC (holo and total) from baseline to 9 months post-partum.
There were no statistically significant associations between the extent of vitamin B 12 supplementation and levels of serum cobalamins, TC and HC (holo and total) at baseline, 4 months or 9 months post-partum. Furthermore, the levels of serum cobalamins, TC and HC (total and holo) after 9 months showed no statistical difference between the groups of supplemented (supplemented with vitamin B 12 at all three visits, N ¼ 25) and unsupplemented (no supplementation with vitamin B 12 at any of the three visits, N ¼ 25) lactating women (data not shown). As expected, the prolactin level decreased (Friedman's test, Po0.0001) from baseline (range 0.04-2.4 IU/l, median ¼ 0.6 IU/l) to 9 months (range 0.01-0.8 IU/l, median ¼ 0.15 IU/l) post-partum. The decrease was not associated with the change in serum cobalamins, TC and HC (holo and total) from baseline to 9 months post-partum.
The levels of serum cobalamins, TC and HC (holo and total) after 9 months for mothers having lactated o8 months (N ¼ 30) and mothers having lactated 48 months (N ¼ 56) were compared. No statistically significant differences in levels of these biomarkers in relation to the extent of lactation were observed (Mann-Whitney test, P40.05). Therefore, the results from all 89 women were analysed together to follow changes in serum cobalamins and its binding proteins post-partum.
No change was observed in serum cobalamins throughout the study period, whereas changes in opposite directions were observed for TC and HC ( Figure 1 and Table 2 ). Total TC decreased statistically significantly from baseline to 9 months post-partum (Friedman's test, Po0.0001) ( Figure 1a and Table 2 ). A significant decrease was seen for holoTC, comparing the level at baseline and at 9 months (Friedman's test, P ¼ 0.0002) ( Figure 1a and Table 2) .
No statistically significant change in the level of total and holoHC was seen when comparing the baseline and the 4 months data (Wilcoxon matched pair signed-ranks test, P40.05). However, comparing the level at 4 and 9 months, a statistically significant increase was observed (Wilcoxon matched pair signed-ranks test, Pp0.01) (Figure 1b and Table 2 ). The baseline levels were significantly associated with the levels at 9 months post-partum for total TC (total HC) (r 2 ¼ 0.51 (r 2 ¼ 0.50)), holoTC (holo HC) (r 2 ¼ 0.93, (r 2 ¼ 0.68)) and TC saturation (HC saturation) (r 2 ¼ 0.66 (r 2 ¼ 0.27)) (Po0.0001). The 95% reference interval for holoHC, total HC and HC saturation determined on plasma from 71 healthy female donors was 220-590 pmol/l (median ¼ 340 pmol/l), 250-760 pmol/l (median ¼ 408 pmol/l) and 0.6-1 pmol/l (median ¼ 0.9 pmol/l), respectively. The HC saturation was significantly higher for women p50 years (95% reference interval ¼ 0.6-1 pmol/l, median ¼ 0.9, n ¼ 36) compared with women 450 years (95% reference interval ¼ 0.7-0.9 pmol/l, median ¼ 0.8, n ¼ 35) (Mann-Whitney test, P ¼ 0.0004). No statistically significant association with age was seen for holo and total HC.
Discussion
The aim of this study was to examine serum cobalamins, HC and TC (holo and total) in lactating women. We found no change in the level of serum cobalamins, whereas the two compartments of serum cobalamins changed in lactating women. HoloTC decreased and holoHC increased from 3 weeks to 9 months post-partum. Also, total TC decreased and total HC increased during the same period.
Information concerning the physiological changes in serum cobalamins and the cobalamin-binding proteins during pregnancy and lactation is limited. Serum cobalamins decrease during pregnancy (Bartels et al., 1989; Willis et al., 1989; Koebnick et al., 2002) , but based on the results from our study and a previous study (Dostálová, 1984) , it normalizes within a few weeks post-partum. These observations are confirmed by comparing the level of serum cobalamins just before birth measured in a previous study (Obeid et al., 2005) with the level 3 weeks postpartum obtained in our study. Between 3 weeks and 9 months post-partum, we found no alteration in serum cobalamins, and the levels obtained were well in accordance with established reference intervals for non-lactating women, Table 2 .
Interestingly, the subfractions of serum cobalamins, holoTC and holoHC changed with time post-partum as did total TC and HC. These changes could be explained by the influence of several factors, such as change in weight of the mother (blood volume), vitamin B 12 supplementation, the extent of lactation and/or hormonal changes during lactation. Surprisingly, our results indicate that the weight decrease of the mother only influences the level of holoHC and cobalamins, whereas holoTC, total TC or total HC were not influenced by the weight change.
We did not find any difference in cobalamins or its binding proteins between the groups of vitamin B 12 -supplemented and unsupplemented lactating mothers. Furthermore, the extent of vitamin B 12 supplementation was not significantly associated with the levels of serum cobalamins, TC or HC (holo and total). Therefore, supplementation with vitamin B 12 does not seem to influence the levels of cobalamins, TC and HC (holo and total). However, no conclusion can be drawn concerning the influence of the vitamin B 12 from the diet.
We observed a decrease in TC and an increase in HC from 3 weeks to 9 months post-partum, changes that are unlikely to be related to the extent of lactation or hormonal changes (prolactin) because no statistically significant association was observed between these parameters.
Comparing the levels of TC and HC obtained 3 weeks postpartum with the levels obtained just before birth using the same ELISA methods (Obeid et al., 2005) , the levels of total proteins (TC and HC) seem to decrease significantly at or just after birth, whereas the levels of holoproteins (TC and HC) seem to increase, significantly. In order to explore this observation, a longitudinal study on pregnant women including samples drawn just before and after birth is needed.
Total and holoTC were relatively high 3 weeks and 4 months post-partum, a time during which the flux of cobalamin through the circulation is expected to be increased because cobalamin has to be delivered to both the mother and through the milk to the baby. The amount of total and holoTC present in the circulation is the sum of the influx minus the efflux. As the efflux of holoTC is likely to be increased during lactation, the relatively high level of holoTC indicates that also the influx is increased. The increased influx could be explained by an increased absorption of cobalamin through the intestine or mobilization of cobalamin stores from the body. The relatively high level of total TC early post-partum combined with the expected increased efflux of the protein suggests an increased synthesis of the protein during lactation. The decrease in total TC can be explained by the increased efflux of holoTC during lactation and/or a decreased synthesis of TC.
Whereas total and holoTC decrease post-partum, the opposite is true for HC. Total HC increases steadily from 3 weeks through 4 and 9 months, whereas holoHC increases from 4 to 9 months post-partum when the mothers decreased their lactation activities. HoloHC levels decrease during pregnancy, whereas total HC, calculated as apo-HC plus holoHC, increases slightly from the second to third trimester (Koebnick et al., 2002) . Our data suggest that the increase in total HC continues, whereas holoHC starts to increase post-partum.
HC is the major vitamin B 12 -binding protein in human milk. Previous animal and human studies indicate that HC in milk mediates vitamin B 12 absorption in infants during the neonatal period (Boass and Wilson, 1963; Gallagher and Foley, 1971; Ford et al., 1975; Trugo et al., 1985; Adkins and Lonnerdal, 2002) . However, the relationship between HC in human serum and milk is unknown.
Our data indicate that measurement of total serum cobalamins in lactating women will be of limited interest if one wants to evaluate the amount of cobalamin available for the cells (i.e. the holoTC). This is in excellent agreement with recent data, suggesting that holoTC rather than cobalamins is a sensitive marker of vitamin B 12 status (Herbert et al., 1990; Nexo et al., 2002; Herrmann et al., 2003; Hvas and Nexo, 2003) .
Our data indicated that levels of TC and HC (holo and total) were independent of the extent of vitamin B 12 supplementation and lactation. These results may indicate that Danish women are supplied with sufficient amounts of nutritional vitamin B 12 to fulfil needs even during prolonged lactation. Our data do not allow us to conclude whether the baby gets a sufficient supply of vitamin B 12 , but judged from the results obtained for the mothers, there seems to be no need for supplementation with vitamin B 12 during lactation in a Danish population of healthy mothers.
In conclusion, we report a decrease in total and holoTC and an increase in total and holoHC in lactating mothers during a 9-month period post-partum. No differences were observed between mothers who were supplemented or not with vitamin B 12 , independent of the length of the lactation period. Thus, supplementation with vitamin B 12 has no impact on the circulating level of serum cobalamins or its binding proteins in a Danish population of lactating mothers.
